找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Universalising Healthcare in India; From Care to Coverag Imrana Qadeer,K. B. Saxena,P. M. Arathi Book 2021 The Editor(s) (if applicable) an

[复制链接]
楼主: morphology
发表于 2025-3-23 12:18:16 | 显示全部楼层
发表于 2025-3-23 16:09:45 | 显示全部楼层
发表于 2025-3-23 19:46:27 | 显示全部楼层
Interrogating the Proposed Universal Healthcare in India Through a ‘Quality’ LensRising health inequalities, catastrophic healthcare costs pushing people below the poverty line, along with glaring gaps between economic growth rates and health status of people have raised many questions about the post-liberalisation health sector reforms in India.
发表于 2025-3-24 02:12:25 | 显示全部楼层
发表于 2025-3-24 03:23:29 | 显示全部楼层
Role of Public Private Partnerships in Ensuring Universal Healthcare for IndiaIn the early 1990s Health Sector Reforms (HSR) undertaken as part of structural adjustment programmes proposed a range of changes in governance, provisioning, financing and resource generation.
发表于 2025-3-24 06:31:07 | 显示全部楼层
发表于 2025-3-24 12:00:51 | 显示全部楼层
Universal Healthcare and Universalising Health Insurance: Examining the Binary Through the RSBY/MSBYThe Rashtriya Swasthya Bima Yojana (RSBY) is a state-funded health insurance scheme in India, targeted at families living Below Poverty Line (BPL).
发表于 2025-3-24 15:14:42 | 显示全部楼层
Aarogyasri Scheme in Andhra Pradesh, India: Some Critical ReflectionsUniversal Health Coverage (UHC) is currently being debated all over the world and the ruling Bharatiya Janata Party (BJP) government in India has now brought in the idea of health assurance.
发表于 2025-3-24 20:36:06 | 显示全部楼层
发表于 2025-3-25 01:04:48 | 显示全部楼层
Drugs and Vaccines in Healthcare: Problems and PossibilitiesThe problems with regard to the use of allopathic drugs in India range from quality and regulation to irrational use because of the nexus between pharmaceutical companies and the largely commercial healthcare establishments. Fake or sub-standard allopathic drugs may represent as much as 25% of our drugs.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-4 20:30
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表